Search all trials

Find therapies in clinical trials near you – page 44

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 968
countries: 28
conditions: 2 103

3 968 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Non-small cell lung cancer

Not recruiting

Registered drug

Study of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Atezolizumab

Contact Research Centre

Prostate cancer metastatic

Not recruiting

Registered drug

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Enzalutamide

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years

Contact Research Centre

Paroxysmal nocturnal haemoglobinuria

Not recruiting

Registered drugNo placebo

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Crovalimab

Contact Research Centre

Systemic candida

Not recruiting

Registered drug

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Anidulafungin

Contact Research Centre

Crohn's disease

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Breast cancer stage IV

Not recruiting

Registered drug

Study of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer

Registered drug

Belgium

Participants:18–64 years · 65+ years
Substances:Eftilagimod Alfa

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer

Registered drugNo placebo

Belgium

Participants:18–64 years · 65+ years
Substances:Budigalimab

Contact Research Centre

Cystic fibrosis

Not recruiting

Registered drugNo placebo

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Registered drugNo placebo

Belgium

Participants:0–17 years · 18–64 years · 65+ years
Substances:Deutivacaftor

Contact Research Centre

Focal segmental glomerulosclerosis+1

Not recruiting

InvestigationalNo placebo

Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

InvestigationalNo placebo

Belgium

Participants:0–17 years · 18–64 years
Substances:R3R01

Contact Research Centre

Colitis ulcerative

Not recruiting

Registered drugNo placebo

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Registered drugNo placebo

Belgium

Participants:0–17 years
Substances:Tofacitinib

Contact Research Centre

Find therapies in clinical trials near you – page 44

638 trials match your criteria

Non-small cell lung cancer

Study of Tiragolumab, Atezolizumab, and Pembrolizumab for Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer

Prostate cancer metastatic

Study of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer

Non-small cell lung cancer

Study on the Effectiveness and Safety of Alectinib, Entrectinib, and a Drug Combination for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

Paroxysmal nocturnal haemoglobinuria

Study Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors

Systemic candida

Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

Crohn's disease

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease

Colitis ulcerative

Study on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Ulcerative Colitis

Breast cancer stage IV

Study of Eftilagimod Alpha and Paclitaxel in Patients with HER2-Negative/Low Metastatic Breast Cancer

Non-small cell lung cancer

Study on Livmoniplimab and Budigalimab with Chemotherapy for Adults with Untreated Metastatic Non-Small Cell Lung Cancer

Cystic fibrosis

Study on Long-term Safety of VX-121, Tezacaftor, and Deutivacaftor in Patients with Cystic Fibrosis

Focal segmental glomerulosclerosis+1

Study on R3R01 for Patients with Alport Syndrome and Primary Steroid-Resistant Focal Segmental Glomerulosclerosis

Colitis ulcerative

Study of Tofacitinib for Children with Moderate to Severe Ulcerative Colitis

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.